Frank Haluska - Net Worth and Insider Trading
Frank Haluska Net Worth
The estimated net worth of Frank Haluska is at least $4 Million dollars as of 2024-04-25. Frank Haluska is the SVP, Clinical R&D, CMO of ARIAD Pharmaceuticals Inc and owns about 147,011 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $4 Million. Details can be seen in Frank Haluska's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank Haluska has not made any transactions after 2016-03-21 and currently still holds the listed stock(s).
Transaction Summary of Frank Haluska
Frank Haluska Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Haluska owns 3 companies in total, including Anchiano Therapeutics Ltd (CMMB) , ARIAD Pharmaceuticals Inc (ARIA) , and Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Frank Haluska’s form 4 insider trades.
Insider Ownership Summary of Frank Haluska
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMMB | Anchiano Therapeutics Ltd | 2020-01-01 | director & Chief Executive Officer |
| ARIA | ARIAD Pharmaceuticals Inc | 2016-04-29 | SVP & Clinical R&D & CMO |
| CMMB | Chemomab Therapeutics Ltd | 2020-01-01 | director & Chief Executive Officer |
Frank Haluska Latest Holdings Summary
Frank Haluska currently owns a total of 1 stock. Frank Haluska owns 147,011 shares of ARIAD Pharmaceuticals Inc (ARIA) as of March 21, 2016, with a value of $4 Million.
Latest Holdings of Frank Haluska
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-21 | 147,011 | 23.99 | 3,526,794 |
Holding Weightings of Frank Haluska
Frank Haluska Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Haluska has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 3,575 shares on March 21, 2016, which brought Frank Haluska around $23,130.
Insider Trading History of Frank Haluska
- 1
Frank Haluska Trading Performance
Frank Haluska Ownership Network
Ownership Network List of Frank Haluska
Ownership Network Relation of Frank Haluska
Frank Haluska Owned Company Details
What does Anchiano Therapeutics Ltd do?
Who are the key executives at Anchiano Therapeutics Ltd?
Frank Haluska is the director & Chief Executive Officer of Anchiano Therapeutics Ltd. Other key executives at Anchiano Therapeutics Ltd include Chief Financial Officer Stephen J. Dipalma , other: Affiliate of 10% Owner Len Blavatnik , and 10 percent owner Access Industries Holdings Llc .
Anchiano Therapeutics Ltd (CMMB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anchiano Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anchiano Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anchiano Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anchiano Therapeutics Ltd Insider Transactions
Frank Haluska Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Haluska. You might contact Frank Haluska via mailing address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
